Theralase Technologies Inc.

Theralase® Technologies Inc. (TSXV: TLT | OTCQB: TLTFF) is a clinical-stage biopharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria, and viruses.

Theralase® was one of the first companies in North America to bring Cool Laser Therapy (CLT) to patients and the first company in the world to bring personalized Anti-Cancer Therapy (ACT) to patients based on their individual tissue characteristics.